Japan· JP-1319758Q2028
ジクアホソルナトリウム
A diquafosol product containing ジクアホソルナトリウム, registered in Japan by 参天製薬, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Diquafosol is registered in 2 of 19 countries.
Countries holding a registration under ATC S01XA33 (diquafosol), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Diquafosol · ATC S01XA33
2 / 19 countries
- Japan
- Norwayprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ジクアホソルナトリウム
- Manufacturer
- 参天製薬
- Country
- Japan (JP)
- ATC code
- S01XA33
- ATC class
- Diquafosol
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01XA33
Diquafosol, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a69021d9-2fea-4875-a397-4db5bf3e8d81 GET /v1/drugs/a69021d9-2fea-4875-a397-4db5bf3e8d81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３％５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1319758Q2028",
"category": "外用薬",
"price_yen": 770.5,
"generic_name": "ジクアホソルナトリウム",
"product_name_jp": null,
"therapeutic_class": "1319",
"transitional_expiry": null
}See everything about diquafosol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.